Latest Tumor markers Stories
Goal of Enabling Affordable, Large-Scale BRCA1 and BRCA2 Screening for General Population FREMONT, Calif., Feb. 19, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc.
Agreement ensures continuing broad patient access to Quest's BRCAvantage(TM) services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb.
-- Findings could lead to new therapies for breast, ovarian, and other cancers NEW YORK, Feb.
A team of UK researchers led by Oxford University scientists has devised a new test that could help doctors diagnose breast cancer earlier by detecting changes in a person’s zinc levels.
An ExitCoachRadio.com story about how two long time friends and musicians are joining together to beat cancer in more ways than one. (PRWEB) November 19, 2014
MONTREAL, Nov. 3, 2014 /CNW Telbec/ - Prostate cancer remains the most common cancer and the third most common cause of cancer-related deaths in Canadian men.
First major service extension to the company's BRCAvantage(TM) BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer MADISON,
Opportunities Being Developed While the Situation with the PCA3 Prostate Cancer Test is Being Resolved QUEBEC CITY, Oct. 30, 2014 /PRNewswire/ - DiagnoCure, Inc.
When you flush the toilet, you may be discarding microscopic warning signs about your health. But a cunningly simple new device can stop that vital information from “going to waste.”
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.